An old cancer drug has been found to play a key role in preventing the rejection of transplanted tissue and researchers at Lund University hope that the discovery can now trigger development of new treatments that may benefit both transplant patients and patients with autoimmune diseases. The researchers behind the study, which has been published in the scientific journal iPLOS ONE/i, work at the Rausing Laboratory, Lund University, where they have conducted ...
via Medindia Health News
More READ
No comments:
Post a Comment